CHICAGO, Feb. 14, 2023 (GLOBE NEWSWIRE) -- An #" Prevalence of SDOH Collection Nearly eight in 10 survey respondents indicated that their organization was collecting SDOH data.
MoonLake Immunotherapeutics announces landmark Phase 2 results for Nanobody® sonelokimab in active psoriatic arthritis 5-11-2023, 23:00